MMWR – Increases in Drug and Opioid-Involved Overdose Deaths — United States,...

From 2014 to 2015, the death rate from synthetic opioids other than methadone, which includes fentanyl, increased by 72.2%, and heroin...

Jan 06, 2017 | Kim Rodgers

  • Reflections from the 2016 Harm Reduction Conference

    Harm reduction is an important movement that started thirty years ago in the early days of the HIV epidemic, when people who inject...

    Dec 06, 2016 | Kim Rodgers

  • Now Available: Facing Addiction in America: The Surgeon General’s Report on Alcohol,...

    On November 17, 2016, the Office of the Surgeon General released Facing Addiction in America: The Surgeon General’s Report on Alcohol,...

    Nov 16, 2016 | Kim Rodgers

  • October is National Youth Substance Use And Substance Use Disorder Prevention Month

    On October 3, 2016, President Obama declared October 2016 as National Youth Substance Use And Substance Use Disorder Prevention Month....

    Oct 04, 2016 | Kim Rodgers

  • Lessons from the 2016 Ryan White Conference

    Last month, NACCHO’s HIV, STI, & Viral Hepatitis team attended the 2016 National Ryan White Conference on HIV Care and Treatment....

    Sep 19, 2016 | Kim Rodgers

  • Opioid Epidemic in Rural America

    The prevalence of substance abuse disorders in the U.S. has increased dramatically in the past 15 years with catastrophic...

    Sep 13, 2016 | Kim Rodgers

  • World Hepatitis Day: What Local Health Departments Can Do to Address a Global Burden

    World Hepatitis Day— today, July 28—brings awareness to the more than 400 million people across the globe who are infected with...

    Jul 28, 2016 | Kim Rodgers

  • HHS Releases Implementation Guidance to Support Syringe Services Programs

    The U.S. Department of Health and Human Services (HHS) has issued guidance regarding the use of Federal funds to implement or expand...

    Mar 29, 2016 | Alyssa Kitlas

  • Narcan® (Naloxone Hydrochloride) Nasal Spray Approved By U.S. Food and Drug...

    The FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In...

    Nov 27, 2015 | Alyssa Kitlas

  • MMWR – Increases in Drug and Opioid-Involved Overdose Deaths — United States, 2010–2015

    From 2014 to 2015, the death rate from synthetic opioids other than methadone, which includes fentanyl, increased by 72.2%, and heroin death rates increased by 20.6%. Rates of death involving heroin and synthetic opioids other than methadone increased across all demographic groups, regions, and in numerous states. Natural/semisynthetic opioid death rates increased by 2.6%, whereas, […]

    Jan 06, 2017 | Kim Rodgers

    Reflections from the 2016 Harm Reduction Conference

    Harm reduction is an important movement that started thirty years ago in the early days of the HIV epidemic, when people who inject drugs and their sex partners were dying of AIDS at alarming rates. Harm reduction is a framework for meeting people where they are at and reducing the negative consequences of drug use. […]

    Dec 06, 2016 | Kim Rodgers

    Now Available: Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs & Health

    On November 17, 2016, the Office of the Surgeon General released Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs & Health. This historic, first-ever report was unveiled at Facing Addiction in America: A National Summit. During the Summit, which is available for viewing, some of the nation’s leading experts discussed the report, which features seven chapters:...

    Nov 16, 2016 | Kim Rodgers

    October is National Youth Substance Use And Substance Use Disorder Prevention Month

    On October 3, 2016, President Obama declared October 2016 as National Youth Substance Use And Substance Use Disorder Prevention Month. In the proclamation, President Obama encourages people to “engage in appropriate programs and activities to promote comprehensive prevention efforts to reduce youth substance use and substance use disorders within their communities.” Stay tuned...

    Oct 04, 2016 | Kim Rodgers

    Lessons from the 2016 Ryan White Conference

    Last month, NACCHO’s HIV, STI, & Viral Hepatitis team attended the 2016 National Ryan White Conference on HIV Care and Treatment. Sponsored by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), the conference convened more than 2,400 grantees, consumers, stakeholders, and healthcare professionals from across...

    Sep 19, 2016 | Kim Rodgers

    Opioid Epidemic in Rural America

    The prevalence of substance abuse disorders in the U.S. has increased dramatically in the past 15 years with catastrophic consequences, especially in rural regions. Deaths and injuries from illegal opioid and heroin use are more prevalent in rural states, and death from opioid overdose is 45 percent higher in rural regions than urban areas. National […]

    Sep 13, 2016 | Kim Rodgers

    World Hepatitis Day: What Local Health Departments Can Do to Address a Global Burden

    World Hepatitis Day— today, July 28—brings awareness to the more than 400 million people across the globe who are infected with chronic viral hepatitis, including up to 150 million living with hepatitis C virus (HCV). In the United States, more than 3.5 million Americans—particularly baby boomers (those born between 1945 and 1965)—are living with HCV, making it the most common chronic […]

    Jul 28, 2016 | Kim Rodgers

    HHS Releases Implementation Guidance to Support Syringe Services Programs

    The U.S. Department of Health and Human Services (HHS) has issued guidance regarding the use of Federal funds to implement or expand syringe services programs (SSPs) for people who inject drugs. The guidance was designed for programs directly funded by HHS interested in implementing or expanding SSPs. SSPs include the provision of sterile needles, syringes, […]

    Mar 29, 2016 | Alyssa Kitlas

    Narcan® (Naloxone Hydrochloride) Nasal Spray Approved By U.S. Food and Drug Administration

    The FDA approved NARCAN® (naloxone hydrochloride) Nasal Spray for the emergency treatment of known or suspected opioid overdose. In 2013, opioid overdose related deaths claimed over 24,500 lives and this number continues to grow. NARCAN Nasal Spray, a ready-to-use, needle-free device, delivers a 4 mg dose of naloxone in a single 0.1 ml nasal spray. NARCAN […]

    Nov 27, 2015 | Alyssa Kitlas

    3 Newsletters1200 1
    Back to Top